Wantai
Wantai
Wantai Bio-Pharmaceutical Co., Ltd. is a high-tech enterprise engaged in the research and development and production of biological diagnostic reagents and vaccines
Wantai Bio-Pharmaceutical Co., Ltd. is a high-tech enterprise engaged in the research and development and production of biological diagnostic reagents and vaccines, with the concept of "science-based, health-conscious", the aim of "quality for survival, scientific and technological innovation for development", and the pursuit of "to contribute to the cause of human health", to transform the achievements of biological technology into high-quality products to serve the public.
- All
- News
- Analysis
- Research
Briefing Jan 18, 2023 10:59 AM
· Healthcare
BlissBio Nets Over CNY 100 Mn in Series B+
Briefing Sep 21, 2022 10:38 AM
· Healthcare
Weiyou Gene Nets Tens of Millions of CNY in Series Pre-A Round
In-depth
Healthcare
China VC Investment List Q4 2022 – Healthcare
For healthcare, we at EqualOcean have identified 20 companies worth watching in Q4 identified by proceedings. We select venture capital investments of over CNY 200 million on average or the equivalent value in USD in a single round.
Jan 05, 2023 06:55 PM
Briefing Sep 16, 2022 11:10 PM
· Healthcare
NaviSeed Nets Tens of millions of CNY in Angel Round
Briefing Sep 13, 2022 05:30 PM
· Healthcare
Nuwacell Nets Hundreds of Mns of CNY in Series A
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 22, 2021 03:11 PM
Briefing Aug 31, 2022 08:30 PM
· Healthcare
Enitiatebio Nets One Hundred Million of CNY in Series A Round
Briefing Jun 28, 2022 09:56 AM
· Healthcare
And platinum medicine b7h4x4-1bb bispecific antibody were approved by FDA for new drug research
Briefing Jun 28, 2022 09:54 AM
· Healthcare
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
Briefing Jun 28, 2022 09:50 AM
· Healthcare
It is expected to achieve functional cure of chronic hepatitis B! GSK antisense therapy phase IIB positive clinical results
Insight
Healthcare
Opportunities and Challenges Hidden in the CGT Industry in China
CGT (Cell and Gene Therapy) is a sector with high growth potential. CAR-T, as one of the main CGT currently, presents great value for both doctors and patients. This article showcases the industry pain points and opportunities faced in the CAR-T sub-sector.
Jan 17, 2023 05:48 PM
Briefing Jun 28, 2022 09:37 AM
· Healthcare
Aibo biology: cooperate with Jiahe biology to jointly develop tumor mRNA drugs
Briefing Oct 15, 2021 06:25 PM
· Healthcare
Wantai biology: it is proposed to raise no more than 3.5 billion yuan for the phase II expansion project of nine price cervical cancer vaccine
Insight
Briefing Sep 02, 2021 02:06 PM
· Healthcare
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
Briefing Jul 29, 2021 10:01 AM
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%
See more
Related Companies
